SLC5A2 and diabetic kidney disease: Studies have demonstrated that NE can also directly activate sodium-glucose cotransporter 2 (SGLT2) expression in proximal tubular epithelial cells, promoting glucose reabsorption—a mechanism of critical importance in diabetic nephropathy and metabolic reprogramming in RCC (15).